Acumen Pharmaceuticals, Inc. (ABOS) Tops Q1 EPS by 4c

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q1 EPS of ($0.33), $0.04 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Could Intel return to the red-hot memory market after $20B raise and recent hire?
• MicroVision prices $17 million public offering at $2.50 per unit